November is celebrated as Lung Cancer Awareness Month all across the globe. The aim is to spread awareness about this deadly disease and lay emphasis on the need for early detection. The early it gets detected, the higher is the chance for survival.
Study Highlights Treatment Options for Early-Stage NSCLC
A large English population-based study has been published in the Journal of Clinical Oncology. It suggests that surgical resection remains the preferred treatment for those with early stage non-small cell lung cancer. Researchers have conducted a retrospective cohort study using the National Cancer Database to evaluate the association between time to treatment and long-term survival. They included 157,894 patients in the study with stage I adenocarcinoma or squamous cell carcinoma. The investigators found significantly higher adjusted three-year-all cause mortality following SABR compared with surgery.
Study Compares Surgery and SABR Outcomes
In this study, the patients were diagnosed between 2015 and 2020 who received either SABR or surgical resection. It was estimated that three-year all-cause mortality was 30.3%, following SABR compared with 21.6% after surgery.
Delays in Treatment May Affect Survival
“Our results suggest that delays beyond 4 weeks may diminish the survival advantage of early-stage disease, underscoring the value of an efficient preoperative pathway,” the study authors wrote. “Rapid-access clinics, coordinated multidisciplinary pathways, and centralized referral systems,” they added, “may help achieve resection within this clinically meaningful window, representing one of the most actionable opportunities to improve survival at a population level.”
Surgery Remains a Key Treatment for Early-Stage NSCLC
The central clinical message is that surgery remains the benchmark for those with early-stage NSCLC. SABR also continues to remain an important option where operative risk, age-related vulnerability favor a non-surgical approach. The team will work towards more mature randomized evidence capable of clarifying comparative survival, camera control and quality of life.
The information shared in this blog is for educational purposes only. You should always consult with your healthcare professional for any medical needs.
Subscribe to our newsletter or follow us on Facebook or X today to stay informed and never miss an update!